Reconstitution and analysis of soluble inhibin and activin receptor complexes in a cell-free system

被引:27
作者
del Re, E
Sidis, Y
Fabrizio, DA
Lin, HY
Schneyer, A
机构
[1] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Med,Reprod Endocrine Unit, Boston, MA 02114 USA
[2] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Program Membrane Biol, Boston, MA 02114 USA
[3] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Renal Unit, Boston, MA 02114 USA
关键词
D O I
10.1074/jbc.M408090200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Activins and inhibins compose a heterogeneous subfamily within the transforming growth factor-beta (TGF-beta) superfamily of growth and differentiation factors with critical biological activities in embryos and adults. They signal through a heteromeric complex of type II, type I, and for inhibin, type III receptors. To characterize the affinity, specificity, and activity of these receptors (alone and in combination) for the inhibin/ activin subfamily, we developed a cell-free assay system using soluble receptor-Fc fusion proteins. The soluble activin type II receptor (sActRII)-Fc fusion protein had a 7-fold higher affinity for activin A compared with sActRIIB-Fc, whereas both receptors had a marked preference for activin A over activin B. Although inhibin A and B binding was 20-fold lower compared with activin binding to either type II receptor alone, the mixture of either type II receptor with soluble TGF-beta type III receptor (TbetaRIII; betaglycan)-Fc reconstituted a soluble high affinity inhibin receptor. In contrast, mixing either soluble activin type II receptor with soluble activin type I receptors did not substantially enhance activin binding. Our results support a cooperative model of binding for the inhibin receptor (ActRII.sTbetaRIII complex) but not for activin receptors (type II + type I) and demonstrate that a complex composed of activin type II receptors and TbetaRIII is both necessary and sufficient for high affinity inhibin binding. This study also illustrates the utility of this cell-free system for investigating hypotheses of receptor complex mechanisms resulting from crystal structure analyses.
引用
收藏
页码:53126 / 53135
页数:10
相关论文
共 43 条
[1]   NOVEL ACTIVIN RECEPTORS - DISTINCT GENES AND ALTERNATIVE MESSENGER-RNA SPLICING GENERATE A REPERTOIRE OF SERINE THREONINE KINASE RECEPTORS [J].
ATTISANO, L ;
WRANA, JL ;
CHEIFETZ, S ;
MASSAGUE, J .
CELL, 1992, 68 (01) :97-108
[2]   A systematic, genome-wide, phenotype-driven mutagenesis programme for gene function studies in the mouse [J].
Nolan, PM ;
Peters, J ;
Strivens, M ;
Rogers, D ;
Hagan, J ;
Spurr, N ;
Gray, IC ;
Vizor, L ;
Brooker, D ;
Whitehill, E ;
Washbourne, R ;
Hough, T ;
Greenaway, S ;
Hewitt, M ;
Liu, XH ;
McCormack, S ;
Pickford, K ;
Selley, R ;
Wells, C ;
Tymowska-Lalanne, Z ;
Roby, P ;
Glenister, P ;
Thornton, C ;
Thaung, C ;
Stevenson, JA ;
Arkell, R ;
Mburu, P ;
Hardisty, R ;
Kiernan, A ;
Erven, H ;
Steel, KP ;
Voegeling, S ;
Guenet, JL ;
Nickols, C ;
Sadri, R ;
Naase, M ;
Isaacs, A ;
Davies, K ;
Browne, M ;
Fisher, EMC ;
Martin, J ;
Rastan, S ;
Brown, SDM ;
Hunter, J .
NATURE GENETICS, 2000, 25 (04) :440-443
[3]   Activins are critical modulators of growth and survival [J].
Brown, CW ;
Li, LN ;
Houston-Hawkins, DE ;
Matzuk, MM .
MOLECULAR ENDOCRINOLOGY, 2003, 17 (12) :2404-2417
[4]   Genetic analysis of the mammalian transforming growth factor-β superfamily [J].
Chang, H ;
Brown, CW ;
Matzuk, MM .
ENDOCRINE REVIEWS, 2002, 23 (06) :787-823
[5]   Enhancement of the antagonistic potency of transforming growth factor-α receptor extracellular domains by coiled coil-induced homo- and heterodimerization [J].
De Crescenzo, G ;
Pham, PL ;
Durocher, Y ;
Chao, H ;
O'Connor-McCourt, MD .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (25) :26013-26018
[6]   In the absence of type III receptor, the transforming growth factor (TGF)-β type II-B receptor requires the type I receptor to bind TGF-β2 [J].
del Re, E ;
Babitt, JL ;
Pirani, A ;
Schneyer, AL ;
Lin, HY .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (21) :22765-22772
[7]   Direct binding of Smad3 and Smad4 to critical TGFβ-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene [J].
Dennler, S ;
Itoh, S ;
Vivien, D ;
ten Dijke, P ;
Huet, S ;
Gauthier, JM .
EMBO JOURNAL, 1998, 17 (11) :3091-3100
[8]   Activin and inhibin binding to the soluble extracellular domain of activin receptor II [J].
Donaldson, CJ ;
Vaughan, JM ;
Corrigan, AZ ;
Fischer, WH ;
Vale, WW .
ENDOCRINOLOGY, 1999, 140 (04) :1760-1766
[9]  
DONALDSON CJ, 1995, BIOCHEM BIOPH RES CO, V184, P310
[10]   Cripto forms a complex with activin and type II activin receptors and can block activin signaling [J].
Gray, PC ;
Harrison, CA ;
Vale, W .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (09) :5193-5198